Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder
- PMID: 20712756
- DOI: 10.1111/j.1399-5618.2010.00838.x
Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder
Abstract
Objectives: Several magnetic resonance imaging studies have found changes in amygdala volumes in adults with mood disorders. The cellular basis for these changes has not been explored in detail. Specifically, it is not known whether differences in the density and/or volume of neurons or glial cells contribute to tissue volume changes seen on magnetic resonance images.
Methods: Postmortem amygdala samples were obtained from the Stanley Foundation Neuropathology Consortium from subjects diagnosed with bipolar disorder (n = 10), major depressive disorder (n = 11), and schizophrenia (n = 9), and from normal controls (n = 14). Samples were first stained with glial fibrillary acidic protein (GFAP) and counter-stained with hematoxylin to ascertain neuron and glia (astrocyte) densities.
Results: No significant differences in neuronal densities were found between groups. However, a reduction in the density of GFAP immunoreactive astrocytes was observed in the amygdala of subjects with major depressive disorder compared to the bipolar disorder, schizophrenia, and normal control postmortem samples.
Conclusions: A decrease in density of GFAP immunoreactive astrocytes in the amygdala of depressed subjects is consistent with prior histologic reports and might contribute to amygdala volume reductions reported in several in vivo neuroimaging studies.
(c) 2010 John Wiley & Sons A/S.
Similar articles
-
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes.Biol Psychiatry. 2004 Mar 15;55(6):563-9. doi: 10.1016/j.biopsych.2003.11.006. Biol Psychiatry. 2004. PMID: 15013824
-
Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder.J Psychiatry Neurosci. 2007 May;32(3):203-10. J Psychiatry Neurosci. 2007. PMID: 17476367 Free PMC article.
-
Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder.J Psychiatr Res. 2012 Aug;46(8):1024-8. doi: 10.1016/j.jpsychires.2012.04.012. Epub 2012 May 8. J Psychiatr Res. 2012. PMID: 22572570
-
Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder.Bipolar Disord. 2008 Feb;10(1):1-37. doi: 10.1111/j.1399-5618.2008.00435.x. Bipolar Disord. 2008. PMID: 18199239 Review.
-
Role of Astrocytes in Major Neuropsychiatric Disorders.Neurochem Res. 2021 Oct;46(10):2715-2730. doi: 10.1007/s11064-020-03212-x. Epub 2021 Jan 7. Neurochem Res. 2021. PMID: 33411227 Review.
Cited by
-
Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers.Transl Psychiatry. 2021 Jun 8;11(1):354. doi: 10.1038/s41398-021-01469-6. Transl Psychiatry. 2021. PMID: 34103475 Free PMC article. Review.
-
Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.Eur J Neurosci. 2021 Jan;53(1):183-221. doi: 10.1111/ejn.14547. Epub 2019 Sep 13. Eur J Neurosci. 2021. PMID: 31421056 Free PMC article. Review.
-
Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.Adv Neurobiol. 2021;26:153-172. doi: 10.1007/978-3-030-77375-5_8. Adv Neurobiol. 2021. PMID: 34888835 Review.
-
Astrocytes in Post-Stroke Depression: Roles in Inflammation, Neurotransmission, and Neurotrophin Signaling.Cell Mol Neurobiol. 2023 Oct;43(7):3301-3313. doi: 10.1007/s10571-023-01386-w. Epub 2023 Jul 20. Cell Mol Neurobiol. 2023. PMID: 37470888 Review.
-
Inflaming sex differences in mood disorders.Neuropsychopharmacology. 2019 Jan;44(1):184-199. doi: 10.1038/s41386-018-0124-7. Epub 2018 Jun 19. Neuropsychopharmacology. 2019. PMID: 29955150 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous